PQQ (Pyrroloquinoline Quinone) is a vitamin-like compound that induces mitochondrial biogenesis. Discovered in 1979, classified as a B-vitamin-like cofactor in 2003. A rare ingredient that increases mitochondrial numbers.

How does it differ from creatine and NMN?

All involve brain energy metabolism but at different layers. PQQ is mitochondrial number (quantity), NMN is NAD+ supply (mitochondrial fuel), creatine is ATP regeneration speed (instant energy). Complementary in long-term brain strategy.

Is 20 mg per day enough?

Current clinical standard is 10-20 mg/day. Dietary PQQ is just 0.1-0.3 mg/day, so cognitive-target clinical doses require supplementation. Safety confirmed up to 40 mg/day.

PQQ 20mg, 6 Weeks: Brain NAA Increase and Orientation Cognition Improved in 34 MCI Seniors

PQQ (Pyrroloquinoline Quinone) effects on brain metabolism and cognition in mild cognitive impairment (MCI) seniors were evaluated in a 2024 ScienceDirect trial. In 34 participants (mean 71.9 years, 28 women) over 6 weeks, dihydrogen-PQQ produced significant effects.

Key Results

Orientation cognition showed significant interaction effects vs. placebo. Orientation (time, place, person recognition) is basic cognitive function that declines early in dementia.

More notable: brain imaging biomarkers:

Cerebral oxygen saturation significantly increased
Brain N-acetylaspartate (NAA) increased at multiple sites

NAA marks neuronal health, reflecting neuron density and function. NAA increase suggests PQQ operates at the neuronal level.

Mitochondrial Biogenesis Induction

PQQ’s unique action is mitochondrial biogenesis. Most ingredients improve existing mitochondrial function; PQQ increases mitochondrial count itself. This fundamentally expands cellular energy production capacity.

Mitochondrial density and efficiency decline with age, especially in high-energy tissues (brain, heart, muscle), driving cognitive, cardiovascular, and strength loss. PQQ responds at the quantity dimension.

20-65 Year Broader Age Range

Other trials covering ages 20-65 found PQQ significantly increased cognitive flexibility and executive speed at 8 and 12 weeks. PQQ works not just in seniors but in younger adults too.

Clinical Dose and Protocol

Dose: 10-20 mg/day (cognition)
Timing: with meals (fat-soluble)
Duration: minimum 8 weeks
Form: BioPQQ (registered trademark) standardized raw material common in trials

NAD+ and Creatine Combinations

PQQ complements brain energy metabolism support:

NAD+ precursors (NMN, NR): supply fuel (NAD+) for mitochondrial operation
Creatine: instant ATP regeneration speed
Omega-3: mitochondrial membrane structure
Coenzyme Q10: electron transport chain support

“Quantity-Fuel-Speed-Structure” four layers together optimize brain energy metabolism.

Dietary Sources

PQQ-containing foods:

Natto: 61 ng/g
Green tea: 30 ng/ml
Parsley: 34 ng/g
Bell peppers: 28 ng/g
Kiwi: 27 ng/g

Diet provides ~0.1-0.3 mg/day, dozens of times below the 10-20 mg clinical dose. Supplementation is necessary for cognitive effects.

Safety

PQQ safety confirmed up to 40 mg/day in animal and human trials. Rare mild headache reported.

Limits

Most PQQ human trials are small and short-term (6-12 weeks), with limited large long-term RCTs. How fully animal findings (mitochondrial number increase, lifespan extension) reproduce in humans requires further research.

Still, from the perspective of “fundamental improvement of brain energy metabolism,” PQQ is establishing itself as a core ingredient in late-2020s longevity and cognitive supplement categories.

Source: ScienceDirect